CYBA and respiratory failure: Concomitant with this, Cyba‐deficient mice showed significantly decreased survival as compared with wild‐type mice (median survival of 60 weeks and 83 weeks, respectively), due to a combination of increased tumour incidence (Figure 3A) and widespread pulmonary granulomas inducing dyspnoea or respiratory failure.